These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37821678)

  • 1. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
    Luan H; Jian L; Huang Y; Guo Y; Zhou L
    Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
    Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
    J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration.
    Wang Y; Zhou D; Kong Y; Yang Q; Ding Y; Wang W
    Biomed Res Int; 2022; 2022():6109052. PubMed ID: 36582601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
    Chen Z; Huang J; Li M; Zhang L; Wan D; Lin S
    Medicine (Baltimore); 2021 Mar; 100(12):e25320. PubMed ID: 33761734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma.
    Xie J; Zhou X; Wang R; Zhao J; Tang J; Zhang Q; Du Y; Pang Y
    Medicine (Baltimore); 2021 Jun; 100(23):e26135. PubMed ID: 34114996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E is a prognostic factor for pancreatic cancer and associates with immune infiltration.
    Wu B; Yang X; Chen F; Song Z; Ding X; Wang X
    Cytokine; 2024 Jul; 179():156628. PubMed ID: 38704962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer.
    Lu Q; Zhang Y; Chen X; Gu W; Ji X; Chen Z
    Medicine (Baltimore); 2021 Mar; 100(12):e24957. PubMed ID: 33761652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
    Cheng T; Chen P; Chen J; Deng Y; Huang C
    Front Genet; 2021; 12():809600. PubMed ID: 35069702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma.
    Fan L; Wang X; Chang Q; Wang Y; Yang W; Liu L
    Medicine (Baltimore); 2022 Oct; 101(42):e30966. PubMed ID: 36281157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
    Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX
    BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
    Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
    Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
    Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H
    Front Oncol; 2021; 11():771099. PubMed ID: 34804973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
    Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
    Front Oncol; 2022; 12():827051. PubMed ID: 35433491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Liu Q; Cui M; Wang M; Hua S; Gao J; Liao Q
    Front Immunol; 2021; 12():774435. PubMed ID: 35046938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma.
    Zuo J; Yi C; Chen Z; Zhou B; Yang T; Lin J
    Sci Rep; 2022 Nov; 12(1):18384. PubMed ID: 36319832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer.
    Liang ZW; Yu J; Gu DM; Liu XM; Liu J; Wu MY; Xu MD; Shen M; Duan W; Li W
    J Cell Mol Med; 2022 Mar; 26(5):1540-1555. PubMed ID: 35150061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.